Previous Article | Next Article 
Journal of Virology, June 2001, p. 5405-5409, Vol. 75, No. 11
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.11.5405-5409.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Integrin
v
1 Is an Adenovirus
Coreceptor
Erguang
Li,
Swati L.
Brown,
Dwayne G.
Stupack,
Xose S.
Puente,
David
A.
Cheresh, and
Glen R.
Nemerow*
Department of Immunology, The Scripps
Research Institute, La Jolla, California 92037
Received 19 January 2001/Accepted 9 March 2001
 |
ABSTRACT |
The human embryonic kidney (HEK293) cell line, commonly used for
recombinant adenovirus (Ad) propagation, does not express the Ad
coreceptor
v
3 or
v
5 integrins, yet these cells are efficiently infected by Ad vectors. Here we demonstrate that Ad binds
to HEK293 cells via the fiber receptor CAR and is subsequently internalized via interaction with integrin
v
1. Function-blocking antibodies directed against
v or
1, but not
3,
5, or
5,
integrin subunits block Ad infection and viral endocytosis. Therefore,
v
1 serves as a coreceptor for Ad infection, and the lack of
3
and/or
5 but the relatively high expression of
v
1 integrins on
certain tumor cell types may explain why these cells are readily transduced by Ad vectors.
 |
TEXT |
Adenovirus (Ad) host cell
entry requires initial attachment to cells mediated by the fiber
interaction with its cellular receptor CAR. The subsequent association
of penton base with
v
3 or
v
5 integrins promotes Ad entry
(1, 21, 23). Integrins are heterodimeric receptors for
extracellular matrix proteins and cell surface counterreceptors.
v
integrins (
v
1,
v
3,
v
5,
v
6, and
v
8)
mediate cell adhesion to various matrix proteins, including
fibronectin, vitronectin, and fibrinogen, that contain an
arginine-glycine-aspartic acid (RGD) sequence (8, 19, 24).
The interaction of the Ad penton base and
v integrin triggers the
activation of several signaling molecules (14) that
promote actin cytoskeletal reorganization and enhance Ad
internalization. Although HEK293 cells have been widely used for
propagation of recombinant Ad vectors, the integrin repertoire of these
cells has not been clearly established. For example, several reports indicate that HEK293 cells do not express
v
3 and
v
5
integrins (10, 18), while another report indicates that
they do (6). Furthermore,
5 integrin-deficient mouse
fibroblast cells support Ad infection, suggesting that other integrins
play a role in Ad infection (11). HEK293 cells were also
reported to express
5
1 and
v
1 integrins (2),
which have been identified as RGD-dependent receptors for both
fibronectin and vitronectin (2, 15, 22). Considering the
fact that soluble fibronectin or RGD-containing peptide reduced Ad
infection (23) and that an
5
1-activating antibody
has been reported to enhance Ad-mediated gene delivery to certain
melanoma cells (4), it was of interest to determine whether Ad uses either
v
1 and/or
5
1 integrins as
alternative receptors for virus internalization.
The role of CAR and
v integrins in Ad infection of HEK293
cells.
To investigate whether CAR or integrins promote Ad
attachment, we preincubated HEK293 cells with an excess of recombinant Ad type 2 (Ad2) fiber protein or with anti-CAR monoclonal antibody (MAb
) (RmcB), with a function-blocking Fab fragment of a penton base MAb
(DAV-1) (20), or with function-blocking
v
5 (P1F6),
5 (P1D6), or nonfunction-blocking
v (LM142) control MAb prior to
measuring the specific binding of 125I-labeled
Ad5 particles (Fig. 1A) as previously
described (13). Pretreatment of cells with recombinant Ad
fiber protein completely blocked 125I-Ad5 binding
to HEK293 cells, and the RmcB antibody also partially blocked binding.
These findings indicated that Ad binding to HEK293 cells is likely
mediated by fiber association with CAR.

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 1.
Adenovirus infection of HEK293 cells is mediated by
fiber and penton base proteins. (A) Fiber protein mediates Ad binding
to HEK293 cells. HEK293 cells (1.5 × 106
cells/sample, in duplicate) in suspension were preincubated with
recombinant Ad2 fiber, penton base (10 µg/ml), the anti-CAR antibody
(RmcB), anti-penton base antibody (DAV-1), or anti-integrin antibodies
at 20 µg/ml at 4°C for 60 min. Specific Ad binding to cells was
determined by using 125I-labeled Ad2 as previously
described (13). (B) Penton base interaction with v
integrins promotes Ad-mediated gene delivery. HEK293 cells
(106 cells/sample) were preincubated with fiber protein,
anti-CAR, anti-penton base, or anti-integrin antibodies (20 µg/ml) as
described above, followed by incubation with Ad.CMV.LacZ
at an MOI of 1 particle/cell at 4°C for another 30 min. The cells
were then warmed to 37°C for 15 min. Noninternalized virus was
removed by trypsinization. Ad-mediated gene delivery was determined at
20 h postinfection by expression of -galactosidase.
Representative data from two independent experiments were plotted as
the mean ± standard deviation.
|
|
Experiments were next performed to determine if CAR and/or integrins
regulate Ad-mediated gene delivery (Fig.
1B). Cells were
infected with
Ad5.CMV.
LacZ at a multiplicity of infection (MOI)
of 1 and
then assayed for

-galactosidase expression at 20 h
postinfection.
As expected from the binding studies, soluble fiber
protein and
anti-CAR antibody significantly inhibited Ad infection.
Furthermore,
anti-penton base antibody (DAV-1) and the

v integrin
function-blocking
antibody (L230) inhibited Ad-mediated gene delivery
by approximately
40%. In contrast, the function-blocking

v

3
(LM609) and

v

5
(P1F6) integrin antibodies failed to significantly
inhibit infection.
These results suggested that other members of the

v integrin
family, such as

v

1, may facilitate Ad infection of
HEK293
cells.
HEK293 cells express
v
1 integrins.
Since conflicting
results have been reported with regard to
v integrin expression
on HEK293 cells (6, 10, 18), we next sought to determine
the repertoire of different
v integrins expressed on HEK293 cells
using flow cytometry. These studies demonstrated that HEK293 cells
expressed significant levels of
v,
5, and
1 integrins (Fig.
2). In contrast,
v
3 and
v
5 integrin expression was undetectable on HEK293 cells, whereas these
v integrins were expressed on A549 cells. To verify integrin expression, cell surface proteins of HEK293 cells were biotinylated and
then solubilized with 1% Nonidet P-40. Cell lysates were then immunoprecipitated with anti-
v, anti-
5, or anti-
1 or with
anti-
v
1 integrin antibodies and then analyzed on a 6% sodium
dodecyl sulfate-polyacrylamide gel under reducing conditions, followed
by immunoblotting with a horseradish peroxidase-conjugated antibiotin
antibody (Sigma, St. Louis, Mo.). As shown in Fig.
3A, the anti-
v antibody (L230) immunoprecipitated two proteins of approximately 155 and 121 kDa. In contrast, the anti-
v
5 (P1F6) and anti-
v
3
(LM609) antibodies failed to immunoprecipitate these integrins,
although both antibodies immunoprecipitated the corresponding
and
chains from A549 cells (Fig. 3B). The 155- and 121-kDa as well as a
200-kDa protein were also recognized by a pan-specific
1 antibody
(P4C10). The 200-kDa protein is likely the
1 integrin subunit, which
is known to form a heterodimer with the
1 integrin subunit. An
5-specific antibody (P1D6) also immunoprecipitated a 155- and a
121-kDa protein. Integrin
5 also associates with the
1 subunit
and exhibits mobility similar to that of the
v integrin subunit.
These findings indicated that
1 integrins form heterodimeric
receptors with
v and
5 but not with
3 and
5 subunits on
HEK293 cells. Moreover, these findings indicated that
v
1 is the
major
v integrin on HEK293 cells. To verify this, we performed
immunoprecipitation detection experiments with an
v
1-specific
antibody (9EG7). As expected, this antibody also immunoprecipitated
155- and 121-kDa proteins on HEK293 cells.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 2.
Flow cytometric analysis of integrin expression on
HEK293 cells. HEK293 or A549 cells were incubated with 20 µg of
anti-integrin antibodies/ml at 4°C for 60 min. Cell surface-bound
antibody was detected by incubation with an
R-phycoerythrin-labeled goat anti-mouse secondary antibody.
Dashed line, secondary antibody control; solid line, indicated integrin
antibodies.
|
|

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 3.
Immunoprecipitation analyses of integrin expression on
HEK293 cells. HEK293 (A) and A549 (B) cells (107 cells)
were detached with 1 mM EDTA and then biotinylated with 1 mg of
sulfo-N-hydroxysuccinimide-biotin. After being washed
with phosphate-buffered saline four times, labeled cells were then
lysed in 1 ml of lysis buffer containing 1% Nonidet P-40 and protease
inhibitors. Lysates from biotinylated cells (equal to 106
cells) were immunoprecipitated with 2 µg of anti-integrin antibodies
followed by capture with protein A/G beads. The immunoprecipitates were
then separated on 6% sodium dodecyl sulfate gels under reducing
conditions. After transfer to a polyvinylidene difluoride membrane, the
filter was probed with a horseradish peroxidase-conjugated anti-biotin
antibody.
|
|
v
1 integrins promote Ad infection of HEK293 cells.
We
next analyzed whether the
v
1 integrins expressed on HEK293 cells
were capable of interacting with Ad by performing cell adhesion assays
in the presence or absence of function-blocking integrin antibodies.
HEK293 cells adhered to fibronectin, and adhesion could be inhibited
with a function-blocking anti-
5 (P1D6), anti-
v (L230), or
anti-
1 (P4C10) MAb (Fig. 4). HEK293
cells also adhered to penton base; however, adhesion to penton base could only be inhibited by anti-
v or the anti-
1 antibodies. This
finding indicated that integrin
v
1 but not
5
1 serves as a
receptor for Ad penton base.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 4.
Integrin-dependent cell adhesion to fibronectin (A) or
penton base (B). Non-tissue culture-treated cluster plates were
precoated with 10 µg of recombinant penton base or fibronectin/ml.
HEK293 cells were preincubated with 20 µg of anti-integrin
antibodies/ml before the cells were allowed to attach to coated plates
for 15 min at 37°C. Attached cells were quantitated after fixation
and stained with crystal violet. Data are presented as the mean ± standard deviation of duplicate samples. Antibodies: LM609,
anti- v 3; P1F6, anti- v 5; L230, anti- v; P4C10, anti- 1;
P1D6, anti- 5; 1973z, anti- 1.
|
|
To determine whether Ad uses

v

1 integrin for infection, we
treated HEK293 cells with anti-

v integrin antibody (L230), anti-

5
antibody (P1D6), or anti-

1 integrin antibody (P4C10) and then
measured Ad-mediated gene delivery to these cells (Fig.
5A). Pretreatment
of HEK293 cells with
anti-

v, anti-

1, or a combination of anti-

v
and anti-

1
antibodies significantly blocked Ad infection. In
contrast, the
anti-

5 antibody alone inhibited Ad infection by
less than 10%.
Pretreatment with a combination of anti-

1 and
anti-

5 antibodies
did not further decrease gene delivery relative
to that achieved with
anti-

1 alone (data not shown). These data
indicated that

v

1
integrin also facilitates Ad infection of
HEK293 cells.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 5.
Integrin v 1 promotes Ad-mediated gene delivery and
virus internalization. (A) HEK293 cells in suspension were preincubated
with anti-integrin antibodies for 60 min at 4°C, followed by
incubation with Ad.CMV.LacZ at an MOI of 1 viral
particle/cell. After being warmed to 37°C for 15 min, noninternalized
virus was removed by trypsinization. Cells were plated in 6-well
plates, and -galactosidase expression was determined at 20 h
postinfection (mean ± standard deviation). (B) HEK293 cells were
pretreated with 20 µg of anti-integrin antibodies/ml at 4°C for 60 min, followed by the addition of 125I-labeled Ad2 (2 × 105 cpm/cell). Bound virus particles were then allowed
to internalize by warming the cells at 37°C for 15 min. Internalized
virions were determined by measuring their resistance to
trypsinization. The data represent the percentage of trysin-resistant
cpm/total cpm of specifically bound Ad ± standard deviation of
duplicate samples.
|
|
Further studies investigated whether penton base interaction with
integrin

v

1 promotes Ad internalization. Cells were preincubated
with function-blocking anti-integrin antibodies prior to the addition
of
125I-labeled Ad2 (Fig.
5B). Virus uptake was
then assayed by measuring
the resistance of Ad particles to trypsin
treatment. Pretreatment
with anti-

1 or anti-

v antibody
significantly inhibited Ad internalization
by 63 and 42%,
respectively, compared to that of untreated control
cells. The
combination of anti-

v and anti-

1 antibodies inhibited
Ad
internalization by 76%. In contrast, the anti-

5 or LM609 antibody
(

v

3) had little if any effect on virus entry. These studies
demonstrated that

v

1 integrin promotes Ad infection by enhancing
virus
internalization.
Here we demonstrated that HEK293 cells use

v

1 integrin, instead
of

v

3 or

v

5 integrin, for virus internalization and
infection. The ability of

v

1 to promote Ad infection may also
explain why mice genetically deficient in

5 integrin are susceptible
to Ad infection (
11). It will be of interest to determine
whether
other cell types that express

v

1 or perhaps other

1
integrins
(
3,
12) are also susceptible to Ad infection. In
this regard,
human melanoma, breast cancer, and neuroblastoma cells
have been
shown to express integrin

v

1 (
5,
7,
9,
16).
Integrin

v

1 may also regulate the migration of human
oligodendritic cells
in the central nervous system (
17).
 |
ACKNOWLEDGMENTS |
We are extremely grateful to David Schlaepfer and Richard Klemke
(The Scripps Research Institute) for valuable discussions and advice.
We thank Joan Gausepohl and Kelly White for preparation of the manuscript.
This work was supported by the NIH (grants HL54352 and EY11431).
 |
FOOTNOTES |
*
Department of Immunology, The Scripps Research
Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037. Phone: (858)
784-8072. Fax: (858) 784-8472. E-mail: gnemerow{at}scripps.edu.
This is manuscript no. 13843-IMM from the Department of Immunology.
 |
REFERENCES |
| 1.
|
Bergelson, J. M.,
J. A. Cunningham,
G. Droguett,
E. A. Kurt-Jones,
A. Krithivas,
J. S. Hong,
M. S. Horwitz,
R. L. Crowell, and R. W. Finberg.
1997.
Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5.
Science
275:1320-1323[Abstract/Free Full Text].
|
| 2.
|
Bodary, S. C., and J. W. McLean.
1990.
The integrin 1 subunit associates with the vitronectin receptor v subunit to form a novel vitronectin receptor in a human embryonic kidney cell line.
J. Biol. Chem.
265:5938-5941[Abstract/Free Full Text].
|
| 3.
|
Croyle, A. M.,
W. E. Janich,
B. J. Roessler, and G. L. Amidon.
1998.
Role of integrin expression in adenovirus-mediated gene delivery to the intestinal epithelium.
Hum. Gene Ther.
9:561-573[Medline].
|
| 4.
|
Davison, E.,
R. M. Diaz,
I. R. Hart,
G. Santis, and J. F. Marshall.
1997.
Integrin 5 1-mediated adenovirus infection is enhanced by the integrin-activating antibody TS2/16.
J. Virol.
71:6204-6207[Abstract/Free Full Text].
|
| 5.
|
Dedhar, S., and V. Gray.
1990.
Isolation of a novel integrin receptor mediating Arg-Gly-Asy-directed cell adhesion to fibronectin and type I collagen from human neuroblastoma cells.
J. Cell Biol.
110:2185-2193[Abstract/Free Full Text].
|
| 6.
|
Dmitriev, I.,
V. Krasnykh,
C. R. Miller,
M. Wang,
E. Kashentseva,
G. Mikheeva,
N. Belousova, and D. T. Curiel.
1998.
An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism.
J. Virol.
72:9706-9713[Abstract/Free Full Text].
|
| 7.
|
Friedlander, D. R.,
D. Zagzag,
B. Shiff,
H. Cohen,
J. C. Allen,
P. J. Kelly, and M. Grumet.
1996.
Migration of brain tumor cells on extracellular matrix proteins in vitro correlates with tumor type and grade and involves v and 1 integrins.
Cancer Res.
56:1939-1947[Abstract/Free Full Text].
|
| 8.
|
Gailit, J., and R. A. Clark.
1996.
Studies in vitro on the role of v and 1 integrins in the adhesion of human dermal fibroblasts to provisional matrix proteins fibronectin, vitronectin, and fibrinogen.
J. Investig. Dermatol.
106:24144-24150.
|
| 9.
|
Heyman, D.,
J. Harb,
S. Ringeard,
F. Blanchard,
D. Lassort,
S. Raher, and A. Godard.
1995.
Upmodulation of v 1 integrin expression on human tumor cells by human interleukin for DA cells/leukemia inhibitory factor and oncostatin M: correlation with increased cell adhesion on fibronectin.
J. Cell. Biochem.
58:305-314[CrossRef][Medline].
|
| 10.
|
Hu, D. D.,
E. Lin,
N. L. Kovach,
J. R. Hoyer, and J. W. Smith.
1995.
A biochemical characterization of the binding of osteopontin to integrins v 1 and v 5.
J. Biol. Chem.
270:26232-26238[Abstract/Free Full Text].
|
| 11.
|
Huang, X.,
M. Griffiths,
J. Wu,
R. V. Farese, Jr., and D. Sheppard.
2000.
Normal development, wound healing, and adenovirus susceptibility in 5-deficient mice.
Mol. Cell. Biol.
20:755-759[Abstract/Free Full Text].
|
| 12.
|
Kasono, K.,
J. L. Blackwell,
J. T. Douglas,
I. Dmitriev,
T. V. Strong,
P. Reynolds,
D. A. Kropf,
W. R. Carroll,
G. E. Peters,
R. P. Bucy,
D. T. Curiel, and V. Krasnykh.
1999.
Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector.
Clin. Cancer Res.
5:2571-2579[Abstract/Free Full Text].
|
| 13.
|
Li, E.,
D. Stupack,
D. Cheresh,
R. Klemke, and G. Nemerow.
1998.
Adenovirus endocytosis via v integrins requires phosphoinositide-3-OH-kinase.
J. Virol.
72:2055-2061[Abstract/Free Full Text].
|
| 14.
|
Li, E.,
D. G. Stupack,
S. L. Brown,
R. Klemke,
D. D. Schlaepfer, and G. R. Nemerow.
2000.
Association of p130cas with phosphatidylinositol-3-OH kinase mediates adenovirus cell entry.
J. Biol. Chem.
275:14729-14735[Abstract/Free Full Text].
|
| 15.
|
Marshall, J. F.,
D. C. Rutherford,
A. C. McCartney,
F. Mitjans,
S. L. Goodman, and I. R. Hart.
1995.
v 1 is a receptor for vitronectin and fibrinogen, and acts with 5 1 to mediate spreading on fibronectin.
J. Cell Sci.
108:1227-1238[Abstract].
|
| 16.
|
Meyer, T.,
J. F. Marshall, and I. R. Hart.
1998.
Expression of v integrins and vitronectin receptor identity in breast cancer cells.
Br. J. Cancer
77:530-536[Medline].
|
| 17.
|
Milner, R.,
G. Edwards,
C. Streuli, and C. Ffrench-Constant.
1996.
A role in migration for the v 1 integrin expressed on oligodendrocyte precursors.
J. Neurosci.
16:7240-7252[Abstract/Free Full Text].
|
| 18.
|
Simon, K. O.,
E. M. Nutt,
D. G. Abraham,
G. A. Rodan, and L. T. Duong.
1997.
The v 3 integrin regulates 5 1-mediated cell migration toward fibronectin.
J. Biol. Chem.
272:29380-29389[Abstract/Free Full Text].
|
| 19.
|
Smith, J. W.,
D. J. Vestal,
S. V. Irwin,
T. A. Burke, and D. A. Cheresh.
1990.
Purification and functional characterization of integrin v 5: an adhesion receptor for vitronectin.
J. Biol. Chem.
265:11008-11013[Abstract/Free Full Text].
|
| 20.
|
Stewart, P. L.,
C. Y. Chiu,
S. Huang,
T. Muir,
Y. Zhao,
B. Chait,
P. Mathias, and G. R. Nemerow.
1997.
Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization.
EMBO J.
16:1189-1198[CrossRef][Medline].
|
| 21.
|
Tomko, R. P.,
R. Xu, and L. Philipson.
1997.
HCAR and MAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses.
Proc. Natl. Acad. Sci. USA
94:3352-3356[Abstract/Free Full Text].
|
| 22.
|
Vogel, B. E.,
G. Tarone,
F. G. Giancotti,
J. Gailit, and E. Ruoslahti.
1990.
A novel fibronectin receptor with an unexpected subunit composition ( v 1).
J. Biol. Chem.
265:5934-5937[Abstract/Free Full Text].
|
| 23.
|
Wickham, T. J.,
P. Mathias,
D. A. Cheresh, and G. R. Nemerow.
1993.
Integrins v 3 and v 5 promote adenovirus internalization but not virus attachment.
Cell
73:309-319[CrossRef][Medline].
|
| 24.
|
Zhang, Z.,
A. O. Morla,
K. Vuori,
J. S. Bauer,
R. L. Tuliano, and E. Ruoslahti.
1993.
The v 1 integrin functions as a fibronectin receptor but does not support fibronectin matrix assembly and cell migration on fibronectin.
J. Biol. Chem.
122:235-242.
|
Journal of Virology, June 2001, p. 5405-5409, Vol. 75, No. 11
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.11.5405-5409.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Dallaire, F., Blanchette, P., Groitl, P., Dobner, T., Branton, P. E.
(2009). Identification of Integrin {alpha}3 as a New Substrate of the Adenovirus E4orf6/E1B 55-Kilodalton E3 Ubiquitin Ligase Complex. J. Virol.
83: 5329-5338
[Abstract]
[Full Text]
-
Jonsson, M. I., Lenman, A. E., Frangsmyr, L., Nyberg, C., Abdullahi, M., Arnberg, N.
(2009). Coagulation Factors IX and X Enhance Binding and Infection of Adenovirus Types 5 and 31 in Human Epithelial Cells. J. Virol.
83: 3816-3825
[Abstract]
[Full Text]
-
Raman, S., Hsu, T.-H., Ashley, S. L., Spindler, K. R.
(2009). Usage of Integrin and Heparan Sulfate as Receptors for Mouse Adenovirus Type 1. J. Virol.
83: 2831-2838
[Abstract]
[Full Text]
-
Veettil, M. V., Sadagopan, S., Sharma-Walia, N., Wang, F.-Z., Raghu, H., Varga, L., Chandran, B.
(2008). Kaposi's Sarcoma-Associated Herpesvirus Forms a Multimolecular Complex of Integrins ({alpha}V{beta}5, {alpha}V{beta}3, and {alpha}3{beta}1) and CD98-xCT during Infection of Human Dermal Microvascular Endothelial Cells, and CD98-xCT Is Essential for the Postentry Stage of Infection. J. Virol.
82: 12126-12144
[Abstract]
[Full Text]
-
Libertini, S., Iacuzzo, I., Ferraro, A., Vitale, M., Bifulco, M., Fusco, A., Portella, G.
(2007). Lovastatin Enhances the Replication of the Oncolytic Adenovirus dl1520 and Its Antineoplastic Activity against Anaplastic Thyroid Carcinoma Cells. Endocrinology
148: 5186-5194
[Abstract]
[Full Text]
-
Logunov, D. Y., Zubkova, O. V., Karyagina-Zhulina, A. S., Shuvalova, E. A., Karpov, A. P., Shmarov, M. M., Tutykhina, I. L., Alyapkina, Y. S., Grezina, N. M., Zinovieva, N. A., Ernst, L. K., Gintsburg, A. L., Naroditsky, B. S.
(2007). Identification of HI-Like Loop in CELO Adenovirus Fiber for Incorporation of Receptor Binding Motifs. J. Virol.
81: 9641-9652
[Abstract]
[Full Text]
-
Li, J., Lad, S., Yang, G., Luo, Y., Iacobelli-Martinez, M., Primus, F. J., Reisfeld, R. A., Li, E.
(2006). Adenovirus Fiber Shaft Contains a Trimerization Element That Supports Peptide Fusion for Targeted Gene Delivery. J. Virol.
80: 12324-12331
[Abstract]
[Full Text]
-
Tuve, S., Wang, H., Ware, C., Liu, Y., Gaggar, A., Bernt, K., Shayakhmetov, D., Li, Z., Strauss, R., Stone, D., Lieber, A.
(2006). A New Group B Adenovirus Receptor Is Expressed at High Levels on Human Stem and Tumor Cells. J. Virol.
80: 12109-12120
[Abstract]
[Full Text]
-
Shieh, G.-S., Shiau, A.-L., Yo, Y.-T., Lin, P.-R., Chang, C.-C., Tzai, T.-S., Wu, C.-L.
(2006). Low-Dose Etoposide Enhances Telomerase-Dependent Adenovirus-Mediated Cytosine Deaminase Gene Therapy through Augmentation of Adenoviral Infection and Transgene Expression in a Syngeneic Bladder Tumor Model.. Cancer Res.
66: 9957-9966
[Abstract]
[Full Text]
-
Asokan, A., Hamra, J. B., Govindasamy, L., Agbandje-McKenna, M., Samulski, R. J.
(2006). Adeno-Associated Virus Type 2 Contains an Integrin {alpha}5{beta}1 Binding Domain Essential for Viral Cell Entry. J. Virol.
80: 8961-8969
[Abstract]
[Full Text]
-
Lord, R., Parsons, M., Kirby, I., Beavil, A., Hunt, J., Sutton, B., Santis, G.
(2006). Analysis of the interaction between RGD-expressing adenovirus type 5 fiber knob domains and {alpha}vbeta3 integrin reveals distinct binding profiles and intracellular trafficking. J. Gen. Virol.
87: 2497-2505
[Abstract]
[Full Text]
-
Godde, N. J., D'Abaco, G. M., Paradiso, L., Novak, U.
(2006). Efficient ADAM22 surface expression is mediated by phosphorylation-dependent interaction with 14-3-3 protein family members. J. Cell Sci.
119: 3296-3305
[Abstract]
[Full Text]
-
Franco, P., Vocca, I., Carriero, M. V., Alfano, D., Cito, L., Longanesi-Cattani, I., Grieco, P., Ossowski, L., Stoppelli, M. P.
(2006). Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and {alpha}v{beta}5 integrin. J. Cell Sci.
119: 3424-3434
[Abstract]
[Full Text]
-
Maginnis, M. S., Forrest, J. C., Kopecky-Bromberg, S. A., Dickeson, S. K., Santoro, S. A., Zutter, M. M., Nemerow, G. R., Bergelson, J. M., Dermody, T. S.
(2006). {beta}1 Integrin Mediates Internalization of Mammalian Reovirus. J. Virol.
80: 2760-2770
[Abstract]
[Full Text]
-
Keriel, A., Rene, C., Galer, C., Zabner, J., Kremer, E. J.
(2006). Canine Adenovirus Vectors for Lung-Directed Gene Transfer: Efficacy, Immune Response, and Duration of Transgene Expression Using Helper-Dependent Vectors. J. Virol.
80: 1487-1496
[Abstract]
[Full Text]
-
Toh, M.-L., Hong, S.-S., Loo, F. v. d., Franqueville, L., Lindholm, L., Berg, W. v. d., Boulanger, P., Miossec, P.
(2005). Enhancement of Adenovirus-Mediated Gene Delivery to Rheumatoid Arthritis Synoviocytes and Synovium by Fiber Modifications: Role of Arginine-Glycine-Aspartic Acid (RGD)- and Non-RGD-Binding Integrins. J. Immunol.
175: 7687-7698
[Abstract]
[Full Text]
-
Zhang, Y., Bergelson, J. M.
(2005). Adenovirus Receptors. J. Virol.
79: 12125-12131
[Full Text]
-
Shayakhmetov, D. M., Li, Z.-Y., Ni, S., Lieber, A.
(2005). Interference with the IL-1-Signaling Pathway Improves the Toxicity Profile of Systemically Applied Adenovirus Vectors. J. Immunol.
174: 7310-7319
[Abstract]
[Full Text]
-
Shayakhmetov, D. M., Eberly, A. M., Li, Z.-Y., Lieber, A.
(2005). Deletion of Penton RGD Motifs Affects the Efficiency of both the Internalization and the Endosome Escape of Viral Particles Containing Adenovirus Serotype 5 or 35 Fiber Knobs. J. Virol.
79: 1053-1061
[Abstract]
[Full Text]
-
Wang, Y., Thorne, S., Hannock, J., Francis, J., Au, T., Reid, T., Lemoine, N., Kirn, D., Hallden, G.
(2005). A Novel Assay to Assess Primary Human Cancer Infectibility by Replication-Selective Oncolytic Adenoviruses. Clin. Cancer Res.
11: 351-360
[Abstract]
[Full Text]
-
Kuhnel, F., Schulte, B., Wirth, T., Woller, N., Schafers, S., Zender, L., Manns, M., Kubicka, S.
(2004). Protein Transduction Domains Fused to Virus Receptors Improve Cellular Virus Uptake and Enhance Oncolysis by Tumor-Specific Replicating Vectors. J. Virol.
78: 13743-13754
[Abstract]
[Full Text]
-
Varghese, R., Mikyas, Y., Stewart, P. L., Ralston, R.
(2004). Postentry Neutralization of Adenovirus Type 5 by an Antihexon Antibody. J. Virol.
78: 12320-12332
[Abstract]
[Full Text]
-
Davydova, J., Le, L. P., Gavrikova, T., Wang, M., Krasnykh, V., Yamamoto, M.
(2004). Infectivity-Enhanced Cyclooxygenase-2-Based Conditionally Replicative Adenoviruses for Esophageal Adenocarcinoma Treatment. Cancer Res.
64: 4319-4327
[Abstract]
[Full Text]
-
Philpott, N. J., Nociari, M., Elkon, K. B., Falck-Pedersen, E.
(2004). Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-{alpha} induction pathway. Proc. Natl. Acad. Sci. USA
101: 6200-6205
[Abstract]
[Full Text]
-
Singh, B., Charkowicz, D., Mascarenhas, D.
(2004). Insulin-like Growth Factor-independent Effects Mediated by a C-terminal Metal-binding Domain of Insulin-like Growth Factor Binding Protein-3. J. Biol. Chem.
279: 477-487
[Abstract]
[Full Text]
-
Salone, B., Martina, Y., Piersanti, S., Cundari, E., Cherubini, G., Franqueville, L., Failla, C. M., Boulanger, P., Saggio, I.
(2003). Integrin {alpha}3{beta}1 Is an Alternative Cellular Receptor for Adenovirus Serotype 5. J. Virol.
77: 13448-13454
[Abstract]
[Full Text]
-
Chung, S.-W., Arnott, J. A., Yang, Y., Wong, P. M. C.
(2003). Presence of Prepackaged mRNA in Virions of DNA Adenovirus. J. Biol. Chem.
278: 50635-50640
[Abstract]
[Full Text]
-
Goldsmith, M. E., Kitazono, M., Fok, P., Aikou, T., Bates, S., Fojo, T.
(2003). The Histone Deacetylase Inhibitor FK228 Preferentially Enhances Adenovirus Transgene Expression in Malignant Cells. Clin. Cancer Res.
9: 5394-5401
[Abstract]
[Full Text]
-
Hong, S. S., Habib, N. A., Franqueville, L., Jensen, S., Boulanger, P. A.
(2003). Identification of Adenovirus (Ad) Penton Base Neutralizing Epitopes by Use of Sera from Patients Who Had Received Conditionally Replicative Ad (Addl1520) for Treatment of Liver Tumors. J. Virol.
77: 10366-10375
[Abstract]
[Full Text]
-
Rieger, R., Kipps, T. J.
(2003). CpG Oligodeoxynucleotides Enhance the Capacity of Adenovirus-mediated CD154 Gene Transfer to Generate Effective B-Cell Lymphoma Vaccines. Cancer Res.
63: 4128-4135
[Abstract]
[Full Text]
-
Duque, H., Baxt, B.
(2003). Foot-and-Mouth Disease Virus Receptors: Comparison of Bovine {alpha}V Integrin Utilization by Type A and O Viruses. J. Virol.
77: 2500-2511
[Abstract]
[Full Text]
-
Volpers, C., Thirion, C., Biermann, V., Hussmann, S., Kewes, H., Dunant, P., von der Mark, H., Herrmann, A., Kochanek, S., Lochmuller, H.
(2003). Antibody-Mediated Targeting of an Adenovirus Vector Modified To Contain a Synthetic Immunoglobulin G-Binding Domain in the Capsid. J. Virol.
77: 2093-2104
[Abstract]
[Full Text]
-
Schoggins, J. W., Gall, J. G. D., Falck-Pedersen, E.
(2003). Subgroup B and F Fiber Chimeras Eliminate Normal Adenovirus Type 5 Vector Transduction In Vitro and In Vivo. J. Virol.
77: 1039-1048
[Abstract]
[Full Text]
-
Koistinen, P., Heino, J.
(2002). The Selective Regulation of alpha Vbeta 1 Integrin Expression Is Based on the Hierarchical Formation of alpha V-containing Heterodimers. J. Biol. Chem.
277: 24835-24841
[Abstract]
[Full Text]
-
Zaiss, A.-K., Liu, Q., Bowen, G. P., Wong, N. C. W., Bartlett, J. S., Muruve, D. A.
(2002). Differential Activation of Innate Immune Responses by Adenovirus and Adeno-Associated Virus Vectors. J. Virol.
76: 4580-4590
[Abstract]
[Full Text]
-
Tibbles, L. A., Spurrell, J. C. L., Bowen, G. P., Liu, Q., Lam, M., Zaiss, A. K., Robbins, S. M., Hollenberg, M. D., Wickham, T. J., Muruve, D. A.
(2002). Activation of p38 and ERK Signaling during Adenovirus Vector Cell Entry Lead to Expression of the C-X-C Chemokine IP-10. J. Virol.
76: 1559-1568
[Abstract]
[Full Text]
-
Jackson, T., Mould, A. P., Sheppard, D., King, A. M. Q.
(2002). Integrin {alpha}v{beta}1 Is a Receptor for Foot-and-Mouth Disease Virus. J. Virol.
76: 935-941
[Abstract]
[Full Text]